Centene Hits Gilead With HIV Generic Antitrust Suit
Managed care company Centene Corp. has hit Gilead Sciences Inc. with an antitrust suit in California federal court, accusing the pharmaceutical giant of conspiring with rivals to prevent generic versions of...To view the full article, register now.
Already a subscriber? Click here to view full article